Bone Biologics (BBLG) - 2025 Q2 - Quarterly Report
Bone Biologics (US:BBLG)2025-08-14 20:30UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission File No. 001-40899 Bone Biologics Corporation (Exact name of registrant as specified in its charter) | | | (State or other juris ...